Ankylosing Spondylitis Serum
About: Ankylosing Spondylitis Serum is collected from donors with clinically confirmed ankylosing spondylitis. Ideal for detecting biomarkers of inflammation, disease progression, and response to biologic therapies.
| Lot Number | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 77405 | Ankylosing Spondylitis | 1.0 ML | Hispanic/Latino | 43 | Female |
None Not taking any medications for hypertension.
|
8 | $495.00 | ||
| 77876 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 62 | Male |
Taltz/80mg/mL/QM Celebrex/200mg/PRN ( has not taken it in long time) Sulfalsalizine QD
|
8 | $495.00 | ||
| 77504 | Ankylosing Spondylitis | 1.0 ML | African American | 67 | Female |
Gabapentin 100 mg TID Enulose Solution Eye Drops TID Timolol 1 gtt QD Kerendia 10 mg QD Adalimumab Injection Q 2 Weeks Rosuvastatin 20 mg QD Esomeprazole 40 mg QD Estradiol 0.1 mg Vaginal Cream Amlodipine-Olmesartan 20/40 mg QD
|
8 | $495.00 | ||
| 77419 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 46 | Male |
Duloxetine 60 mg QD Remicade Q8 weeks Methotrexate 7.5 mg QD Folic Acid 1 mg QD Modafinil 100 mg QD Olmesartan 40/25 mg QD Meloxicam 15 mg QD
|
8 | $495.00 | ||
| 72201 | Ankylosing Spondylitis | 1.0 ML | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
8 | $495.00 | ||
| 71615 | Ankylosing Spondylitis | 1.0 ML | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
3 | $495.00 | ||
| 76540 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 54 | Female |
Rosuvastatin 40 MG tablet, metoPROLOL succinate 25 MG 24 hr tablet, losartan 50 MG tablet, ezetimibe 10 MG tablet, fluoxetine 60 MG capsule Voquezna 20 MG Tab gabapentin 100 MG capsule Quetiapine 25 MG tablet Xeljanz XR 11 MG TABLET SR 24 HR Phentermine 37.5 mcg QD
|
8 | $495.00 | ||
| 71399 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 82 | Male | United States (US) |
Celecoxib 200mg QD Gabapentin 600mg BID Atorvastatin 20mg QD Metoprolol 25mg QD Tamsulosin 0.4mg QD
|
6 | $495.00 | |
| 71484 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 23 | Male | United States (US) |
Naproxyn 500 mg QD
|
6 | $495.00 | |
| 71582 | Ankylosing Spondylitis | 1.0 ML | Caucasian Hispanic/Latino | 46 | Male | United States (US) |
Tramadol 50 mg PRN
|
6 | $495.00 |
Human Ankylosing Spondylitis Serum for Research
Our Ankylosing Spondylitis Human Serum is sourced from IRB-consented donors clinically diagnosed with Ankylosing Spondylitis. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for disease-specific and immunological studies focused on ankylosing spondylitis.
Product Features
- Collected from clinically confirmed Ankylosing Spondylitis donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
De-identified Donor Data
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported medical history and comorbidities
Applications
- Biomarker discovery for ankylosing spondylitis
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Ankylosing Spondylitis serum is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Serum Isolation
Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Serum
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Serum cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.